Virax Biolabs Group Ltd Share Price

NASDAQ: VRAX

Small Cap

$0.61

-0.02

(-3.19%)

as on September 18, 2025 at 1:28 am IST

$₹

Virax Biolabs Group Ltd Stock Performance

as on September 18, 2025 at 1:28 am IST

Day's Low
Day's High
$0.59
Day's Price Range
$0.63
$0.61
3.28%
Downside
3.28%
Upside
52 Week's Low
52 Week's High
$0.52
52-Week Price Range
$3.62
$0.61
14.72%
Downside
493.44%
Upside

Virax Biolabs Group Ltd share price movements today

Previous Close: $0.63
Open: $0.60
Volume: 1.1M
Day's Low - High: $0.59 - $0.63
52 Week Low - High: $0.52 - $3.62

Virax Biolabs Group Ltd Historical Returns

1 Month Return: -18.68 %
3 Month Return: -23.16 %
1 Year Return: -78.05 %
3 Year Return: -97.61 %
5 Year Return: 0 %

Virax Biolabs Group Ltd Stock Fundamentals & Key Indicators

Check Virax Biolabs Group Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8M

EPS (TTM)

-1.48

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

22684300.00%

Virax Biolabs Group Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Virax Biolabs Group Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Virax Biolabs Group Ltd	NA	$2.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Virax Biolabs Group Ltd Stock including INR - Dollar returns

The Virax Biolabs Group Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Virax Biolabs Group Ltd investment value today

Current value as on today

₹25,853

Returns

₹74,147

(-74.15%)

Returns from Virax Biolabs Group Ltd Stock

₹78,746 (-78.75%)

Dollar Returns*

₹4,598 (+4.6%)

Virax Biolabs Group Ltd Stock's Interest Amongst Investors

Search interest for Virax Biolabs Group Ltd Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:16% versus previous 30 day period

Virax Biolabs Group Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Jun 2024	Sep 2024
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	0	0	-1	-1	-4	-4	-2	-3	-2
EBITDA	0	0	0	-1	0	0	0	-2	-3	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	0	0	0	-1	-1	-4	-4	-2	-3	-2
Income Tax Expense	0	0	0	0	-1	-4	-4	0	0	0
Net Income	0	0	0	-1	-1	-4	-4	-2	-3	-2
Net Profit Margin	-1784.58%	-525.54%	460.23%	1245.26%	-25062.69%	-143301.79%	-143301.79%	-3803.47%	-4784.70%	-55651.67%

Virax Biolabs Group Ltd Annual Profit & Loss

All numbers in Millions USD

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Revenue	0	0	-	0	0	0
Gross Profit	0	0	-	0	0	0
Operating Income	0	0	-1	-5	-6	-6
EBITDA	0	0	0	-5	-6	-5
Interest Expense	0	0	0	0	0	0
Depreciation	-	-	-	-	0	0
Income Before Tax	0	0	-1	-5	-6	-6
Income Tax Expense	0	0	-1	0	0	0
Net Income	0	0	-1	-5	-6	-6
Net Profit Margin	-802.13%	-525.75%	0.00%	-63748.32%	-4304.81%	-95739.17%

Virax Biolabs Group Ltd Quarterly Cash Flow

All numbers in Millions USD

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Jun 2024	Sep 2024
Net Income	0	0	-1	-1	-4	-4	-2	-3	-2
Operating Cash Flow	0	0	0	-2	-1	-1	-3	-2	-1
Investing Cash Flow	-	-	0	0	0	0	0	0	0
Financing Cash Flow	0	0	0	6	6	6	0	1	5
Change in Cash	0	0	0	4	4	4	-4	-1	3

Virax Biolabs Group Ltd Annual Cash Flow

All numbers in Millions USD

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Income	-1	-5	-6	-6
Operating Cash Flow	0	-4	-6	-4
Investing Cash Flow	0	0	-1	0
Financing Cash Flow	0	13	1	5
Change in Cash	0	9	-5	0

Global Institutional Holdings in Virax Biolabs Group Ltd

Funds	Holdings
UBS Group AG	0.52%
TWO SIGMA SECURITIES, LLC	0.31%
Citadel Advisors Llc	0.31%
HRT FINANCIAL LLC	0.31%
XTX Topco Ltd	0%

See all

Insights on Virax Biolabs Group Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.82M → -2.75M (in $), with an average increase of 38.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, VRAX stock has moved up by 8.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 146.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 214.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 79.91K → 4.95K (in $), with an average decrease of 93.8% per quarter

About Virax Biolabs Group Ltd

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).

Organisation	Virax Biolabs Group Ltd
Headquarters	BioCity Glasgow, Lanarkshire, United Kingdom, ML1 5UH
CEO	Mr. James Foster
E-voting on shares	Click here to vote

Key Management of Virax Biolabs Group Ltd

Name	Title
Mr. James Foster	Chairman, CEO & Principal Accounting Officer
Dr. Nigel McCracken M.Sc., Ph.D.	COO & Director
Mr. Clement Monteil	Head of Scientific Research & Development
Ms. Lily Fu	Head of Supply Chain

FAQs

What is Virax Biolabs Group Ltd share price today?

Virax Biolabs Group Ltd share price today is $0.61 as on September 18, 2025 at 1:28 am IST at the close of the market. Virax Biolabs Group Ltd share today touched a day high of $0.63 and a low of $0.59.

What is the 52 week high and 52 week low for Virax Biolabs Group Ltd share?

Virax Biolabs Group Ltd share touched a 52 week high of $3.62 on October 23, 2024 and a 52 week low of $0.52 on September 5, 2025. Virax Biolabs Group Ltd stock price today i.e. September 18, 2025 at 1:28 am IST is closed at $0.61,which is 83.15% down from its 52 week high and 17.26% up from its 52 week low.

What is Virax Biolabs Group Ltd's market capitalisation today?

Virax Biolabs Group Ltd market capitalisation is $0.00T as on September 18, 2025 at 1:28 am IST.

How to invest in Virax Biolabs Group Ltd Stock (VRAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Virax Biolabs Group Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Virax Biolabs Group Ltd Shares that will get you 2.4590 shares as per Virax Biolabs Group Ltd share price of $0.61 per share as on September 18, 2025 at 1:28 am IST.

What is the minimum amount required to buy Virax Biolabs Group Ltd Stock (VRAX) from India?

Indian investors can start investing in Virax Biolabs Group Ltd (VRAX) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 1:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Virax Biolabs Group Ltd stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 1:39 am IST). Based on Virax Biolabs Group Ltd share’s latest price of $0.61 as on September 18, 2025 at 1:28 am IST, you will get 16.3934 shares of Virax Biolabs Group Ltd. Learn more about fractional shares .